Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newman Carbomer, officially known as Anhui Newman Fine Chemicals, is a leading specialized manufacturer of carbomers and polyacrylic acid polymers used extensively in the pharmaceutical, personal care, and home care industries. The company focuses on the production of high-purity excipients that serve as thickening, suspending, and stabilizing agents in various drug formulations, including topical gels, oral liquids, and controlled-release tablets. Newman Carbomer operates large-scale manufacturing facilities that adhere to international quality standards such as ISO and GMP, positioning itself as a key global supplier of carbomer products. Their portfolio includes various grades of carbomers designed to meet specific viscosity and clarity requirements for both medical and cosmetic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newman Carbomer.